Dr. Rafii is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4510 Executive Dr
San Diego, CA 92121Phone+1 858-657-8540Fax+1 858-657-8557- Is this information wrong?
Education & Training
- Johns Hopkins UniversityResidency, Neurology, 2003 - 2006
- Johns Hopkins UniversityInternship, Internal Medicine, 2002 - 2003
- The Warren Alpert Medical School of Brown UniversityClass of 2002
Certifications & Licensure
- CA State Medical License 2006 - 2026
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- Down Syndrome Biomarker Initiative (DSBI) Start of enrollment: 2013 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach.Sonal Sukreet, Robert A Rissman, Michael S Rafii> ;Alzheimer's & Dementia. 2024 Apr 14
- Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder.Jonathan D Santoro, Mellad M Khoshnood, Saba Jafarpour, Lina Nguyen, Natalie K Boyd, Benjamin N Vogel, Ryan Kammeyer, Lina Patel, Melanie A Manning, Angela L Rachubins...> ;Annals of Clinical and Translational Neurology. 2024 Apr 1
- Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder.Jonathan D Santoro, Saba Jafarpour, Mellad M Khoshnood, Natalie K Boyd, Benjamin N Vogel, Lina Nguyen, Laura E Saucier, Rebecca Partridge, Emmanuelle Tiongson, Leigh R...> ;American Journal of Medical Genetics. Part A. 2024 May 1
- Join now to see all
Journal Articles
- Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer DiseaseReisa Sperling, Michael S Rafii, Gary Romano, JAMA Neurology
Press Mentions
- Alzheimer's Meds Are Here. But for the down Syndrome Community, It's Still the 1980sMarch 1st, 2023
- Top Dementia Scientists Present Key Findings, InitiativesNovember 28th, 2022
- It’s Not a Normal Sign of Aging: Mild Cognitive Impairment Takes TollApril 19th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: